124 related articles for article (PubMed ID: 26541303)
1. Antibody fragment-armed mesoporous silica nanoparticles for the targeted delivery of bevacizumab in ovarian cancer cells.
Zhang Y; Guo J; Zhang XL; Li DP; Zhang TT; Gao FF; Liu NF; Sheng XG
Int J Pharm; 2015 Dec; 496(2):1026-33. PubMed ID: 26541303
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy.
Sun JG; Jiang Q; Zhang XP; Shan K; Liu BH; Zhao C; Yan B
Int J Nanomedicine; 2019; 14():1489-1501. PubMed ID: 30880960
[TBL] [Abstract][Full Text] [Related]
3. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
[TBL] [Abstract][Full Text] [Related]
4. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
5. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
6. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
Zheng J; Tian X; Sun Y; Lu D; Yang W
Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
[TBL] [Abstract][Full Text] [Related]
7. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.
Zheng G; Shen Y; Zhao R; Chen F; Zhang Y; Xu A; Shao J
J Agric Food Chem; 2017 Aug; 65(32):6904-6911. PubMed ID: 28771340
[TBL] [Abstract][Full Text] [Related]
8. Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye.
Xie M; Shi H; Ma K; Shen H; Li B; Shen S; Wang X; Jin Y
J Colloid Interface Sci; 2013 Apr; 395():306-14. PubMed ID: 23394807
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
10. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
[TBL] [Abstract][Full Text] [Related]
11. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy.
Pan G; Jia TT; Huang QX; Qiu YY; Xu J; Yin PH; Liu T
Colloids Surf B Biointerfaces; 2017 Nov; 159():375-385. PubMed ID: 28818782
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery.
He H; Xiao H; Kuang H; Xie Z; Chen X; Jing X; Huang Y
Colloids Surf B Biointerfaces; 2014 May; 117():75-81. PubMed ID: 24632033
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic Effects of Phosphonate-Functionalized Mesoporous Silica Nanoparticles.
Menon N; Leong DT
ACS Appl Mater Interfaces; 2016 Jan; 8(3):2416-22. PubMed ID: 26741564
[TBL] [Abstract][Full Text] [Related]
15. A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: superoxide dismutase.
Chen YP; Chen CT; Hung Y; Chou CM; Liu TP; Liang MR; Chen CT; Mou CY
J Am Chem Soc; 2013 Jan; 135(4):1516-23. PubMed ID: 23289802
[TBL] [Abstract][Full Text] [Related]
16. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
[TBL] [Abstract][Full Text] [Related]
17. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
18. A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex.
He L; Chen T; You Y; Hu H; Zheng W; Kwong WL; Zou T; Che CM
Angew Chem Int Ed Engl; 2014 Nov; 53(46):12532-6. PubMed ID: 25220408
[TBL] [Abstract][Full Text] [Related]
19. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
20. Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer.
Matthaiou EI; Barar J; Sandaltzopoulos R; Li C; Coukos G; Omidi Y
Int J Nanomedicine; 2014; 9():1855-70. PubMed ID: 24790428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]